Sfoglia per Autore
Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA
1995 Dall'Olio, F; Chiricolo, M; Lollini, P; Lau, J T
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
2002 Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P.-L.; De Giovanni C.; Landuzzi L.; Picci P.
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine
2004 DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L
Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells
2004 CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANNI C; NANNI P.; LOLLINI P-L
45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003
2004 Giavazzi R; Aglietta M; Astolfi A; Falanga A; Fusco A; Labianca R; Lollini PL; Lombardo C; Natali PG; Pierotti MA; Presta M; Santoro M; Taraboletti G; Zupi G; Vecchio G
Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity.
2004 DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P. L.
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions.
2004 QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S.; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F.
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent
2004 NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO E; MUSIANI P; FORNI G; LOLLINI P-L
Immunological prevention of a multigene cancer syndrome
2004 CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORNI G; NANNI P.; LOLLINI P-L
Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies.
2004 Tanzarella S; Lionello I; Valentinis B; Russo V; Lollini PL; Traversari C.
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
2004 Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F.
New target antigens for cancer immunoprevention
2005 Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P.
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity.
2005 Spadaro M; Ambrosino E; Iezzi M; Di Carlo E; Sacchetti P; Curcio C; Amici A; Wei WZ; Musiani P; Lollini PL; Cavallo F; Forni G.
Cancer immunoprevention
2005 P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni
Modeling and simulation of cancer immunoprevention vaccine.
2005 Pappalardo F; Lollini PL; Castiglione F; Motta S.
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice.
2005 Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani P; Forni G; Calogero RA.
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario.
2005 Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; Cavallo F; Calogero RA.
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention
2005 F. Cavallo; A. Astolfi; M. Iezzi; F. Cordero; P.-L. Lollini; G. Forni; R. Calogero
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
2005 Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL.
Modelling vaccination schedules for a cancer immunoprevention vaccine.
2005 S. Motta; F. Castiglione; P.-L. Lollini; F. Pappalardo
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA | Dall'Olio, F; Chiricolo, M; Lollini, P; Lau, J T | 1995-01-01 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - | 1.01 Articolo in rivista | - |
| Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells | Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P....-L.; De Giovanni C.; Landuzzi L.; Picci P. | 2002-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12 engineered allogeneic cell vaccine | DE GIOVANNI C; NICOLETTI G; LANDUZZI L; ASTOLFI A; CROCI S; COMES A; FERRINI S; MEAZZA R; IEZZI M...; DI CARLO E; MUSIANI P; CAVALLO F; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells | CROCI S; LANDUZZI L; ASTOLFI A; NICOLETTI G; ROSOLEN A; SARTORI F; FOLLO MY; OLIVER N; DE GIOVANN...I C; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| 45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003 | Giavazzi R; Aglietta M; Astolfi A; Falanga A; Fusco A; Labianca R; Lollini PL; Lombardo C; Natali... PG; Pierotti MA; Presta M; Santoro M; Taraboletti G; Zupi G; Vecchio G | 2004-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
| Apc10.1: an ApcMin/+ intestinal cell line with retention of heterozygosity. | DE GIOVANNI C.; LANDUZZI L.; NICOLETTI G.; ASTOLFI A.; CROCI S.; MICARONI M.; NANNI P.; LOLLINI P.... L. | 2004-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. | QUAGLINO E.; ROLLA S.; IEZZI M.; SPADARO M.; MUSIANI P.; DE GIOVANNI C.; LOLLINI P.L.; LANZARDO S....; FORNI G.; SANGES R.; CRISPI S.; DE LUCA P.; CALOGERO R.; CAVALLO F. | 2004-01-01 | THE JOURNAL OF CLINICAL INVESTIGATION | - | 1.01 Articolo in rivista | - |
| Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent | NANNI P.; LANDUZZI L; NICOLETTI G; DE GIOVANNI C; ROSSI I; CROCI S; ASTOLFI A; IEZZI M; DI CARLO ...E; MUSIANI P; FORNI G; LOLLINI P-L | 2004-01-01 | JOURNAL OF IMMUNOLOGY | - | 1.01 Articolo in rivista | - |
| Immunological prevention of a multigene cancer syndrome | CROCI S; NICOLETTI G; LANDUZZI L; DE GIOVANNI C; ASTOLFI A; MARINI C; DI CARLO E; MUSIANI P; FORN...I G; NANNI P.; LOLLINI P-L | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Rhabdomyosarcomas are potential target of MAGE-specific immunotherapies. | Tanzarella S; Lionello I; Valentinis B; Russo V; Lollini PL; Traversari C. | 2004-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. | Quaglino E; Iezzi M; Mastini C; Amici A; Pericle F; Di Carlo E; Pupa SM; De Giovanni C; Spadaro M...; Curcio C; Lollini PL; Musiani P; Forni G; Cavallo F. | 2004-01-01 | CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| New target antigens for cancer immunoprevention | Lollini PL; Nicoletti G; Landuzzi L; De Giovanni C; Nanni P. | 2005-01-01 | CURRENT CANCER DRUG TARGETS | - | 1.01 Articolo in rivista | - |
| Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. | Spadaro M; Ambrosino E; Iezzi M; Di Carlo E; Sacchetti P; Curcio C; Amici A; Wei WZ; Musiani P; L...ollini PL; Cavallo F; Forni G. | 2005-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Cancer immunoprevention | P.L. Lollini; C. De Giovanni; T. Pannellini; F. Cavallo; G. Forni; P. Nanni | 2005-01-01 | FUTURE ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Modeling and simulation of cancer immunoprevention vaccine. | Pappalardo F; Lollini PL; Castiglione F; Motta S. | 2005-01-01 | BIOINFORMATICS | - | 1.01 Articolo in rivista | - |
| A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. | Lo Iacono M; Cavallo F; Quaglino E; Rolla S; Iezzi M; Pupa SM; De Giovanni C; Lollini PL; Musiani... P; Forni G; Calogero RA. | 2005-01-01 | INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario. | Astolfi A; Rolla S; Nanni P; Quaglino E; De Giovanni C; Iezzi M; Musiani P; Forni G; Lollini PL; ...Cavallo F; Calogero RA. | 2005-01-01 | CANCER IMMUNOLOGY, IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention | F. Cavallo; A. Astolfi; M. Iezzi; F. Cordero; P.-L. Lollini; G. Forni; R. Calogero | 2005-01-01 | BMC BIOINFORMATICS | - | 1.01 Articolo in rivista | an integrated.pdf |
| Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. | Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musi...ani P; Cavallo F; Forni G; Nanni P; Lollini PL. | 2005-01-01 | THE AMERICAN JOURNAL OF PATHOLOGY | - | 1.01 Articolo in rivista | - |
| Modelling vaccination schedules for a cancer immunoprevention vaccine. | S. Motta; F. Castiglione; P.-L. Lollini; F. Pappalardo | 2005-01-01 | IMMUNOME RESEARCH | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile